Navigation Links
Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007
Date:11/20/2007

_____

Earnings per

share, par value

NIS 1 each

(in NIS) 0.29 0.23 0.10 0.01 0.27

_________ _________ _________ _________ _________

_________ _________ _________ _________ _________

Oil Refineries Ltd.

Selected Pro-forma Consolidated Data from the Report of the Board of

Directors on the State of the Corporation's Affairs for the Period

In millions of NIS In millions of NIS

Unaudited Unaudited

Nine months ended Three months ended

September 30, September 30,

2007 2006 2007 2006

Actual Pro forma Actual Pro forma

Revenues

Refining 14,555 15,013 5,133 4,985

Polymers 971 715 347 177

Aromatics 1,615 1,386 589 419

Cancellation of intercompany

transactions (893) (408) (262) (128)

______ ______ ______ ______

Total 16,248 16,706 5,807 5,453

--------- --------- --------- ---------

Cost of sales, refining and

services

Refining 13,612 14,196 4,898 4,852

Polymers 832 661 296 189

Aromatics 1,449 1,300 537 407

Cancellation of intercompany

transactions (893) (408) (262) (128)


'/>"/>

SOURCE Oil Refineries Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 PuraMed BioScience ® , ... of over-the-counter (OTC) medicinal and healthcare products, announced ... the company based on low market capitalization valuation. ... All Natural Product to Treat Migraine Headaches ... Prescription Competitor , Currently Available Nationwide at ...
(Date:5/23/2013)... HILLS, Calif. , May 23, 2013  Saddleback ... recently became the first hospital on the ... robotic technology. This new surgical option provides women with ... Marc Winter , M.D., ... gynecologist and surgeon and medical director of minimally invasive ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
(Date:5/23/2013)... 23, 2013 Pusan National University Yangsan ... biotherapeutics and contract research company focused on research ... announced today a publication reporting the induction of ... oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex ... in the May 15 th , 2013 issue ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3
... Director Nominees on the Blue Proxy Card TodayRiskMetrics ... 15 Amylin Pharmaceuticals, Inc. (Nasdaq: ... response to a report issued by RiskMetrics Group ... of Stockholders to be held on May 27, ...
... , May 15 Interleukin Genetics, Inc. (NYSE Amex: ... presenting at the BIO 2009 Business Forum on Wednesday, May ... the Sheraton Atlanta Hotel in Atlanta, GA. Lewis H. Bender, ... to include the Company,s business model, available genetic tests and ...
... Calif., May 15 Fate Therapeutics, Inc. ... intellectual property rights jointly owned by Children,s Hospital Boston ... compositions and methods for supporting hematopoietic stem cells. ... of the Stem Cell Program at Children,s Hospital Boston ...
Cached Biology Technology:Amylin Comments on RiskMetrics Report 2Amylin Comments on RiskMetrics Report 3Amylin Comments on RiskMetrics Report 4Amylin Comments on RiskMetrics Report 5Interleukin Genetics to Present at the 2009 BIO Business Forum 2Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Children's Hospital Boston and Massachusetts General Hospital 2Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Children's Hospital Boston and Massachusetts General Hospital 3
(Date:5/22/2013)... Trial (NLST) investigators also conclude that the 20 ... computed tomography (LDCT) versus chest X-ray (CXR) screening ... achievable at experienced screening centers in the United ... share with their patients about the benefits and ... publication in the New England Journal of ...
(Date:5/22/2013)... novel technique that can detect molecular variants in chemical ... of the most important, though time-consuming, processes in analytical ... Nature , post-doctoral researcher David Patterson, Professor of ... Center for Free-Electron Laser Science (CFEL) in Hamburg, Germany ... to identify molecular variants apart, and to determine how ...
(Date:5/22/2013)... Md. (May 22, 2013)The omega 3 fatty acids in ... cardiovascular diseaseso much so that the American Heart Association ... a week, particularly fatty varieties rich in omega 3s. ... a mystery. In a new study, scientists led by ... on this phenomenon by providing evidence that fish oil ...
Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3Detecting mirror molecules 2Detecting mirror molecules 3Fish oil may help the heart beat mental stress 2
... the expansion of oxygen-deficient or oxygen minimum zones (OMZs), also ... carbon is captured and sequestered on the seafloor and alter ... ocean carbon sequestration. Despite the importance of these effects, very ... how they respond to environmental changes. In the Oct. ...
... 2009 A bioethicist who specializes in moral dilemmas families ... with the first-ever March of Dimes Distinguished Lectureship in Perinatal ... John D. Lantos, MD, a nationally-recognized pediatrician and ethicist, ... Different" at the American Society of Bioethics and Humanities, 11th ...
... sex-based biological differences extend to genetic expression in cerebral ... later divergences in how our brains develop. This is ... Elena Jazin and Bjrn Reinius, which has been published ... Psychiatry . Professor Elena Jazin and doctoral student ...
Cached Biology News:Model microbial community for studying expanding dead zones characterized 2Model microbial community for studying expanding dead zones characterized 3March of Dimes establishes 2 new perinatal bioethics awards 2Sex-based prenatal brain differences found 2
...
... Solid phase reagent for ... Easy & unique water ... with detergents and chaotropes; ... recover non-envelop viruses while ...
Synaptic Vesicle I Sampler Kit 10g each...
Mouse monoclonal [3A7.A11] to Thymidylate Synthase ( Abpromise for all tested applications). entrezGeneID: 7298 SwissProtID: P04818...
Biology Products: